• Setting the Scene: Global Action Plan on Antimicrobial Resistance
  Marc Sprenger, World Health Organization
• DRIVE-AB: part of a global collaboration for combating AMR
  Pierre Meulien, Innovative Medicines Initiative
• DRIVE-AB: Vision – Aims – Achievements
  Stephan Harbarth, DRIVE-AB and University of Geneva
  
• Governance and finance recommendations
  Christine Årdal, DRIVE-AB and Norwegian Institute of Public Health
• How do we capture the societal value of antibiotics? (Preliminary findings only, please do not cite)
  Ramanan Laxminarayan, DRIVE-AB, University of Strathclyde, and Center for Disease Dynamics, Economics and Policy
• The need to increase R&D push incentives and effective pipeline co-ordination
  Ursula Theuretzbacher, DRIVE-AB and Center for Anti-Infective Agents
• A review of proposed models, their implementation and how they deliver on each of the DRIVE-AB pillars
  David Findlay, DRIVE-B and GlaxoSmithKline

• What is Net Present Value and why is it killing my research?
  Steven Projan, MedImmune

 

Back to Conference Downloads and Resources.

Back to DRIVE-AB Outputs: Slide Sets.